Canon Medical Partners with Cleerly to Tackle Heart Disease, the Leading Cause of Death

Canon Medical Systems, USA joins forces with Cleerly in a strategic partnership to support simple and streamlined adoption of cardiac CT and create a new standard of care in heart disease. Together, the companies aim to support broader adoption of cardiac CT for the diagnosis and triage of heart disease.

The collaboration agreement brings together the latest cardiac CT technologies, designed to simplify and automate CT acquisition, with auto-generated reporting based on advanced whole-heart atherosclerosis analysis. The result is comprehensive, consistent, and accessible care poised to advance the fight against this deadly disease.

“Cleerly is delighted to announce its partnership with Canon, which will for the first time combine Cleerly’s cutting-edge whole-heart quantification and plaque characterization algorithms with Canon’s industry-leading high-definition CT acquisition and reconstruction technology,” says Dr. James Min, founder and CEO, Cleerly. “This groundbreaking partnership will equip physicians with heretofore unseen levels of precision when treating patients, enabling true prevention at scale.”

The collaboration comes at a pivotal moment. Because of recent scientific developments in cardiac disease management, CT is positioned as a first-line tool in the diagnosis and triage of coronary artery disease. But the complexities of introducing a new imaging service-line, and the challenges of reader variability, have hampered widespread adoption of cardiac CT.

The Canon/Cleerly solution directly addresses these challenges by offering AI-enabled whole-heart atherosclerosis evaluation with auto-generated reports supporting consistent and clinically relevant results. Whether customers want to build a new advanced cardiac CT imaging program from the ground up or already have an existing one, this integrated solution is expected to help accelerate and enhance cardiac CT programs. These programs are more important than ever before to meet the growing cardiovascular needs of healthcare providers: Today, heart attacks account for one in every four deaths. In addition, a heart attack or death is often the first symptom of heart disease in more than 50% of individuals diagnosed with coronary artery disease.

Canon Medical Systems has a long track record of innovation in cardiac care. This includes creating one-beat cardiac CT for conventional and spectral imaging and a robust portfolio of cardiac CT imaging solutions, including the award-winning Vitrea advanced visualization applications. These solutions enable comprehensive cardiac assessments that are consistent and accessible across care providers and patients. By adding Cleerly’s innovative digital care pathway to Canon’s product line-up, Canon is delivering on a commitment to offer meaningful technologies that simplify the care process and enhance clinical insights.

“Once again, Canon has harnessed its strengths and expertise to address pressing healthcare problems, such as heart disease,” says Yuji Hamada, president and CEO, Canon Medical Systems, USA. “This partnership is yet another example of how we find creative solutions to serve our customers and help them deliver the highest levels of care.”

Hot this week

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.